NCT04185220
- Conditions
- Adult T-Cell Lymphoma/Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Sezary Syndrome
Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.
35 public trials
8 recruiting studies
Sezary Syndrome trial results
NCT03905135
- Conditions
- Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT04955340
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Covance Clinical research Unit Ltd. Leeds, United Kingdom
Completed
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
NCT01134341
- Conditions
- Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States
Completed
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
NCT02652715
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, +76 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Completed
Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)
NCT00091559
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
Not specified
Completed
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level
NCT01396070
- Conditions
- Cutaneous Lymphoma, Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
Completed
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
NCT00611208
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Yale University School Of Medicine Recruiting New Haven, Connecticut, United States
- James Graham Brown Cancer Center Louisville, Kentucky, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00178841
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT00099593
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- University of Pittsburgh Medical Center, Department of Dermatology Pittsburgh, Pennsylvania, United States